StonvexLoading…
StonvexStonvexStonvexCore line items from INSW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $325.48M | $843.30M | $575.42M | $379.04M |
Operating Income | $288.56M | $345.38M | $207.22M | $128.54M |
Net Income | $286.14M | $309.26M | $181.76M | $111.21M |
EPS (Diluted) | $5.75 | $6.23 | $3.67 | $2.25 |
Total Assets | $2.87B | $2.67B | $2.79B | $2.52B |
Total Liabilities | $677.07M | $648.37M | $855.79M | $623.44M |
Cash & Equivalents | $141.85M | $116.92M | $412.57M | $148.81M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 49.50M | 49.40M | 49.37M | 49.37M |